This study is accepting new patients by invitation only
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy
Summary
- Eligibility
- for people ages 2-53 (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- bluebird bio
- ID
- NCT04628585
- Study Type
- Observational
- Participants
- Expecting 85 study participants
- Last Updated